| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/06/2008 | EP1953165A1 Aza-substituted spiro derivative |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
| 08/06/2008 | EP1951842A1 Use of rylene derivatives as photosensitizers in solar cells |
| 08/06/2008 | EP1951725A1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951690A1 Heterocyclic cetp inhibitors |
| 08/06/2008 | EP1951235A2 Novel crystal forms of irinotecan hydrochloride |
| 08/06/2008 | EP1951231A2 Camptothecin derivatives as chemoradiosensitizing agents |
| 08/06/2008 | EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/06/2008 | CN101238133A Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 08/06/2008 | CN101238132A Spirochromanone derivatives as acetyl coenzyme A carboxylase(ACC) inhibitors |
| 08/06/2008 | CN100408582C Homocamptoth-ecine compounds, their preparation process and use |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408550C Method for synthesizing camptothecin-relating compounds |
| 08/05/2008 | US7408062 Rigidized trimethine cyanine dyes |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407969 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 08/05/2008 | US7407968 Compounds |
| 08/05/2008 | US7407967 Cyclopamine analogues and methods of use thereof |
| 08/05/2008 | CA2331593C Metabolites of ecteinascidin 743 |
| 07/31/2008 | WO2008005456A3 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 07/31/2008 | WO2007121453A3 2-hydroxy-1-oxo 1,2 dihydro isoquinoline chelating agents |
| 07/31/2008 | US20080182990 Process for the Preparation of Irinotecan Hydrochloride Trihydrate |
| 07/31/2008 | US20080182869 Method of Racemization of the R(-) Isomer of the (2-Chlorophenyl)-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)-Acetic Acid Methyl Ester |
| 07/31/2008 | US20080182868 Novel chemical compounds |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1950196A1 Method for manufacturing ammonium hexafluorphosphates |
| 07/30/2008 | EP1948824A2 Fluorogenic probes for reactive oxygen species |
| 07/30/2008 | CN101233140A Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 07/30/2008 | CN101233139A Alpha-(aryl-or heteroaryl-methyl)-beta-piperidinopropanoic acid compounds as ORL1-receptor antagonists |
| 07/30/2008 | CN101233123A Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2- tetrahydropyran carboxylic acid |
| 07/30/2008 | CN101233119A Novel heterocyclic nf-kb inhibitors |
| 07/30/2008 | CN101232882A Percutaneously absorbable ophthalmic preparation |
| 07/30/2008 | CN101230066A Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| 07/30/2008 | CN100406460C Novel derivative of camptothecine, preparing method and use |
| 07/30/2008 | CN100406456C Process for preparing scopine esters |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406013C Camptothecin derivatives |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405302 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 07/29/2008 | US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | US7405208 Benzoquinone ansamycins |
| 07/29/2008 | CA2460939C Substituted pyrazolyl compounds for the treatment of inflammation |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2401952C Pyranoindoles for treating glaucoma |
| 07/24/2008 | WO2008089453A2 Inhibitors of d-amino acid oxidase |
| 07/24/2008 | WO2008088689A1 Substituted spirochromanone derivatives as acc inhibitors |
| 07/24/2008 | WO2008088688A1 Substituted spirochromanone derivatives as acc inhibitors |
| 07/24/2008 | WO2008024497A3 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 07/24/2008 | WO2008020269A3 A method of treating tumors with azaxanthones |
| 07/24/2008 | WO2007149560A9 Fermentation and purification of actinomadura chromoprotein and related species |
| 07/24/2008 | WO2007098462A3 Trans-fused chromenoisoquinolines, synthesis and methods for use |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | CA2676432A1 Inhibitors of d-amino acid oxidase |
| 07/24/2008 | CA2674573A1 Substituted spirochromanone derivatives |
| 07/23/2008 | EP1945647A2 Processes for preparation of maytansinol |
| 07/23/2008 | EP1945646A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1342723B1 Indole derivatives and use thereof in medicines |
| 07/22/2008 | US7402639 Narrow moleculae weight distribution; addition piolymers; process control |
| 07/22/2008 | US7402593 (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazo[4,5-b]pyridine; proton pump inhibitor (PPI) to treat gastro-oesophageal reflux, digestive bleeding and dyspepsia; enantiomer; long duration of action; longer half-life in plasma; oxidation of sulfide followed by salt formation |
| 07/22/2008 | CA2474511C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/17/2008 | WO2008086409A1 5-furopyridinone substituted indazoles |
| 07/17/2008 | WO2008085480A1 A novel and economical process for preparing (s,s)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer |
| 07/17/2008 | WO2008084005A1 Spiropiperidine glycinamide derivatives |
| 07/17/2008 | WO2008083729A1 Radiolabelling via fluorination of aziridines |
| 07/17/2008 | WO2008060767A3 Macrocyclic benzofused pyrimidine derivatives |
| 07/17/2008 | WO2008056257A3 Novel triazinedione derivatives as gaba-b receptor modulators |
| 07/17/2008 | WO2007120648A3 Mono and di-substituted oxycodone compounds and compositions |
| 07/17/2008 | US20080171888 Process for making spirolactone compounds |
| 07/17/2008 | US20080171856 Antibodies; tissue-targeted therapy; for treatment of tumors, autoimmune diseases, graft rejections, graft versus host disease, viral infections, parasite infections |
| 07/17/2008 | US20080171761 Substituted spirochromanone derivatives |
| 07/17/2008 | US20080171760 e.g. N-[(4-Chlorophenyl)(phenyl)methyl]-2-oxo-2-(1'H,3H-spiro[2-indane-1,4'-piperidin]-1'-yl)ethanamine; vasopressin V1a receptor antagonist; antidepressant, anxiolytic, hypotensive agent; dysmenorrhea, chronic heart failure, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 07/17/2008 | US20080171759 e.g. N-[(4-Chlorophenyl)(phenyl)methyl]-2-oxo-2-(1'H,3H-spiro[2-benzofuran-1,4'-piperidin]-1'-yl)ethanamine; vasopressin V1a receptor antagonist; antidepressant, anxiolytic, hypotensive agent; dysmenorrhea, chronic heart failure, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 07/17/2008 | US20080171740 5,6,7,8-tetrahydro-8-quinolinamines as chemokine receptor CXCR4 antagonists such as N-(Imidazo[1,2-a]pyridin-2-ylmethyl)-N-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-butanediamine; HIV infection, rheumatoid arthritis; antiinflammatory, anticarcinogenic agent |
| 07/17/2008 | US20080171733 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
| 07/17/2008 | US20080171040 Antibody-drug conjugates and methods |
| 07/17/2008 | CA2674958A1 Spiropiperidine glycinamide derivatives |
| 07/17/2008 | CA2674408A1 Radiolabelling via fluorination of aziridines |
| 07/17/2008 | CA2673635A1 5-furopyridinone substituted indazoles |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944288A1 Radiolabelling via fluorination of aziridines |
| 07/16/2008 | EP1944027A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 07/16/2008 | EP1943253A1 Novel crystalline forms |
| 07/16/2008 | EP1943222A1 Antibacterial active 5-chinolin derivative |
| 07/16/2008 | EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/16/2008 | EP1073654B1 2,3-olefinic epothilone derivatives |
| 07/16/2008 | CN101223175A Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP |
| 07/16/2008 | CN101223146A Modulators of ATP-binding cassette transporters |
| 07/16/2008 | CN101220037A 10-substitution homocamptothecin compounds and uses |
| 07/16/2008 | CN101220036A Extraction of active ingredient such as betulinic acid from common camptotheca fruit with clean method |
| 07/16/2008 | CN101220035A A kind of alkaloid, method for preparing the same and application in antineoplastic or antimicrobial aspects |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/15/2008 | US7399861 side effects reduction; treating an obstructive disease of the respiratory tract or for treating overactive bladder; 3-oxa-9-azatricyclo(3.3.1.0(2,4)nonane derivatives |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/10/2008 | WO2008083356A1 Substituted triazoles useful as axl inhibitors |